Clinical Trial Update: Short and Long-Term Effectiveness of Existing Insomnia Therapies for Patients Undergoing Hemodialysis [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluated short- and long-term effectiveness of existing insomnia therapies in patients undergoing hemodialysis (end-stage renal disease).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease
• Insomnia

Snippet

Sponsor: University of Washington | Conditions: Insomnia, End Stage Renal Disease | Phase 3 | Status: COMPLETED | Results posted: 2024-02-05